Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
626 participants
INTERVENTIONAL
2024-10-01
2028-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
However, 20-40% of patients with AUD are lost to follow-up at an early stage. Consequently, it is important for addiction departments to implement and evaluate innovative tools and interventions, including the involvement of peer support, to help patients remain in care, and to assess whether peer support has a positive impact on their clinical outcome.
Addiction peer support specialists (APSSs) are individuals who have personally experienced addiction, and who have decided to use their experience to assist other people going through a similar situation, after completing a specific official graduation.
Compared to other caregivers, APSSs may induce in patients a sense of identification which could improve the patient motivation to engage and remain in care.
This is the main hypothesis and the main scientific objective of the PEERSIAD study, which will aim to confirm that accompanying patients with AUD using APSSs after alcohol detoxification, reduces the rate of lost-to-follow-up and improves the overall clinical outcome.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Life in Patients With Alcohol Use Disorder
NCT04748822
Evaluation of the Implementation of a Parenting Program in Parents With Children Aged 4 to 12 Years and One Parent With an Alcohol Use Disorders
NCT05490589
Improving Help-seeking Propensity Through a Micro-intervention Targeting Common Concerns Among Individuals With Alcohol Problems: A Randomized Controlled Experiment
NCT06675812
Examination of Whether an Exercise Programme Reduces Alcohol Consumption Among Alcohol-Dependent Adults
NCT03848000
Efficacy of a Brief Alcohol Intervention for Non Dependant Alcohol-misusing Patients Undergoing a Scheduled Surgery
NCT01348113
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Peer support Group
313 patients will be recruited over 3 years in the peer support group. Patients will be accompanied by an addiction peer support specialist, as part of an "add-on" follow-up compared with conventional follow-up (same management as in the control group).
Quality life questionnaire AQoLS
Quality life questionnaire AQoLS will be completed by patients of both arms at inclusion, three and six months after inclusion
Quality life questionnaire Euroqol EQ-5D-5L
Quality life questionnaire Euroqol EQ-5D-5L will be completed by patients of both arms at inclusion, three and six months after inclusion
Peer support consultations
For patients included in the Peer support group, eight mandatory consultations with a peer support specialist will be performed between the inclusion visit and during the three following months.
Patients can request additional consultations with the peer support specialist during the 6 first months of follow-up
Control Group
313 patients will be recruited over 3 years in the control group. Patients will receive "as usual" outpatient abstinence-maintenance follow-up, with consultations of all kinds (medical, psychological, nursing, group, etc.)
Quality life questionnaire AQoLS
Quality life questionnaire AQoLS will be completed by patients of both arms at inclusion, three and six months after inclusion
Quality life questionnaire Euroqol EQ-5D-5L
Quality life questionnaire Euroqol EQ-5D-5L will be completed by patients of both arms at inclusion, three and six months after inclusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quality life questionnaire AQoLS
Quality life questionnaire AQoLS will be completed by patients of both arms at inclusion, three and six months after inclusion
Quality life questionnaire Euroqol EQ-5D-5L
Quality life questionnaire Euroqol EQ-5D-5L will be completed by patients of both arms at inclusion, three and six months after inclusion
Peer support consultations
For patients included in the Peer support group, eight mandatory consultations with a peer support specialist will be performed between the inclusion visit and during the three following months.
Patients can request additional consultations with the peer support specialist during the 6 first months of follow-up
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Socially insured
* Meeting DSM-5 criteria for alcohol use disorder (AUD)
* Abstinent from alcohol and involved in supervised alcohol withdrawal for at least 5 days and no more than 21 days (outpatient or inpatient)
* Starting a post-detoxification outpatient program
Exclusion Criteria
* Patient under protective measure (safeguard measure, guardianship) or deprived of liberty or in ordered care and hospitalization measures without consent.
* Inability to communicate and express oneself orally in French, compromising the possibility of exchanges between the Peer support and the patient.
* Psychiatric or cognitive comorbidities making inclusion impossible, at the investigator's discretion.
* Individual accompaniment by a Peer support in the 15 days prior to inclusion.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Benjamin ROLLAND
Role: PRINCIPAL_INVESTIGATOR
Hopsices Civils de Lyon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CH Le Vinatier
Bron, , France
Hôpital Beaujon
Clichy, , France
GH Nord, Hospices Civils de Lyon
Lyon, , France
CHS St Anne
Paris, , France
Bichat Hospital
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Benjamin ROLLAND, Professor
Role: primary
Clément VANSTEENE, MD-PhD
Role: primary
Clément
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL22_0901
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.